Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease

• Date: 2021
• Main Authors: Tronko, M.D., Cherviakova, S.A., Pushkarev, V.V., Belchina, Y.B., Kovzun, O.I., Pushkarev, V.M., Sokolova, L.K.
• Format: Article
• Language: English
• Published: Видавничий дім "Академперіодика" НАН України 2021
• Series: Доповіді НАН України
• Subjects: Біохімія
• Online Access: http://dspace.nbuv.gov.ua/handle/123456789/180577
• Journal Title: Digital Library of Periodicals of National Academy of Sciences of Ukraine
• Cite this: Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease / M.D. Tronko, S.A. Cherviakova, V.V. Pushkarev, Y.B. Belchina, O.I. Kovzun, V.M. Pushkarev, L.K. Sokolova // Доповіді Національної академії наук України. — 2021. — № 4. — С. 110-113. — Бібліогр.: 10 назв. — англ.

Increased levels of high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A1 (ApoA1) in plasma is associated with a reduced risk of developing cardiovascular diseases (CVD). In addition to its potential cardioprotective function, HDL and ApoA1, the main HDL apolipoprotein, also have antidi...